Radionuclide treatment of neuroendocrine tumours with the novel radiolabelled analogue Y-90-SMT 487

Radionuclide treatment of neuroendocrine tumours with the novel radiolabelled analogue Y-90-SMT 487

Podrobná bibliografie
Hlavní autoři:	Carroll, P, Maher, K, Foley, R, Stewart, P, Bevan, J, Franklyn, J, Besser, G, Monson, J, Britton, K, Grossman, AB
Médium:	Journal article
Vydáno:	2003

Podobné jednotky

Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and X-ray computed tomography: a comparative study.
Autor: King, C, a další
Vydáno: (1993)

Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide.
Autor: Ur, E, a další
Vydáno: (1993)

Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
Autor: Kaltsas, G, a další
Vydáno: (2005)

Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
Autor: Kaltsas, G, a další
Vydáno: (2001)

The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours.
Autor: Kaltsas, G, a další
Vydáno: (2001)

Advances in Radionuclides and Radiolabelled Peptides for Cancer Therapeutics
Autor: Kushal Chakraborty, a další
Vydáno: (2023-03-01)

Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.
Autor: Kaltsas, G, a další
Vydáno: (1998)

The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging.
Autor: Johnston, L, a další
Vydáno: (1996)

Targeted radionuclide therapy for neuroendocrine tumours: principles and application.
Autor: Druce, MR, a další
Vydáno: (2010)

MRI of pancreatic neuroendocrine tumours.
Autor: Owen, N, a další
Vydáno: (2001)

Radiolabeling Technique of Silver Nanoparticles (AgNPs) with Iodine-131 Radionuclide
Autor: U.N. Sholikhah, a další
Vydáno: (2020-08-01)

Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.
Autor: Kaltsas, G, a další
Vydáno: (2004)

Radionuclide imaging of neuroendocrine tumors
Autor: Šaponjski Jelena, a další
Vydáno: (2020-01-01)

Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration.
Autor: Jenkins, P, a další
Vydáno: (2000)

Modular strategic SMT solving with SMT-RAT
Autor: Kremer Gereon, a další
Vydáno: (2018-08-01)

The role of somatostatin analogues in the treatment of neuroendocrine tumours.
Autor: Grozinsky-Glasberg, S, a další
Vydáno: (2008)

Radiolabeled Dendrimer Coated Nanoparticles for Radionuclide Imaging and Therapy: A Systematic Review
Autor: Miriam Conte, a další
Vydáno: (2023-03-01)

RADIONUCLIDE IMAGING AND THERAPY OF NEUROENDOCRINE TUMOURS
Autor: Shaunak Navalkissoor, a další
Vydáno: (2015-11-01)

Pituitary imaging using a labelled somatostatin analogue in acromegaly.
Autor: Ur, E, a další
Vydáno: (1992)

Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms.
Autor: Grozinsky-Glasberg, S, a další
Vydáno: (2008)

Familial paraganglioma: a novel presentation of a case and response to therapy with radiolabelled MIBG.
Autor: Lawrence, J, a další
Vydáno: (2004)

Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracil.
Autor: Kaltsas, G, a další
Vydáno: (2002)

Ytrium 90 as a radionuclide for therapy
Autor: Alejandro Alberti Ramírez
Vydáno: (2012-07-01)

487 Abstract withdrawn
Vydáno: (2023-11-01)

Radionuclide imaging and therapy in patients with neuroendocrine tumors
Autor: Olga D. Baranova, a další
Vydáno: (2018-03-01)

The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: avoidance of negative therapeutic uptake due to stunning.
Autor: Siddiqi, A, a další
Vydáno: (2001)

Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours
Autor: Marianne S. Elston, a další
Vydáno: (2021-12-01)

Neuroendocrine Tumours : From Radiomolecular Imaging to Radionuclide Therapy
Autor: GEORGIOS eLIMOURIS
Vydáno: (2012-02-01)

The diagnosis and medical management of advanced neuroendocrine tumors.
Autor: Kaltsas, G, a další
Vydáno: (2004)

The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres
Autor: Mark A. Westcott, MD, a další
Vydáno: (2016-10-01)

Physiologically Based Pharmacokinetic (PBPK) model for biodistribution of radiolabeled peptides in patients with neuroendocrine tumours
Autor: Viktor Popov, a další
Vydáno: (2016-07-01)

Successful neoadjuvant peptide receptor radionuclide therapy for an inoperable pancreatic neuroendocrine tumour
Autor: Tiago Nunes da Silva, a další
Vydáno: (2018-04-01)

Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Autor: Korbonits, M, a další
Vydáno: (1998)

Evaluation of carrier added (CA) and no carrier added (NCA) 177Lu radionuclide roles in radiolabeling of peptide groups
Autor: S. Vosoughi, a další
Vydáno: (2020-11-01)

Peptide receptor radionuclide therapy of neuroendocrine tumors: Case series
Autor: Matović Milovan
Vydáno: (2012-01-01)

I-123 imaging for the prediction of I-131 therapy for recurrent differentiated thyroid cancer, RDTC, when I-131 tracer is negative but raised thyroglobulin, Tg
Autor: Britton, K, a další
Vydáno: (1999)

Spinal cord compression after radiolabeled metaiodobenzylguanidine analogue therapy in advanced malignant insulinoma
Autor: Alina Coutinho Rodrigues Feitosa, a další

The traceless Staudinger ligation for indirect 18F-radiolabelling.
Autor: Carroll, L, a další
Vydáno: (2011)

487 peserta sertai Webinar Antarabangsa
Autor: Isa, Siti Suriawati, a další
Vydáno: (2020)

Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI.
Autor: Rockall, A, a další
Vydáno: (2009)